Analyses of EFS From Date of CR
| Variable . | Median EFS4-150 (95% CI) . | Univariate P Value4-151 . | Multivariate P Value . |
|---|---|---|---|
| inv16 or t(8; 21) | None [62, −] | .086 | NS |
| Complex −5, −7 | 20 [14, 24] | <.001 | <.001 |
| Other abnormal or IM | 41 [34, 51] | <.001 | <.001 |
| Normal karyotype | 83 [70, 129] | <.001 | — |
| PS ≤ 2 | 55 [43, 63] | .006 | .005 |
| PS > 2 | 24.5 [16, 75] | — | |
| IA | 70 [48, 127] | .13 | — |
| IA + G | 79 [63, 99] | .008 | NS |
| F + A | 27 [19, 61] | .022 | NS |
| FLAG | 42 [30, 63] | .27 | NS |
| FLAG + Ida | 36 [27, 43] | .001 | NS |
| RAEB | 22.5 [18-87] | .017 | NS |
| RAEB-t | 55 [36-77] | .78 | NS |
| AML | 55 [43-68] | .26 | — |
| Age | Decreases with increasing age, effect disappears by 40 wk post-CR | <.001 | .033 |
| AHD | Decreases with length of AHD up to plateau at AHD of 10-20 mo | <.001 | .017 |
| Variable . | Median EFS4-150 (95% CI) . | Univariate P Value4-151 . | Multivariate P Value . |
|---|---|---|---|
| inv16 or t(8; 21) | None [62, −] | .086 | NS |
| Complex −5, −7 | 20 [14, 24] | <.001 | <.001 |
| Other abnormal or IM | 41 [34, 51] | <.001 | <.001 |
| Normal karyotype | 83 [70, 129] | <.001 | — |
| PS ≤ 2 | 55 [43, 63] | .006 | .005 |
| PS > 2 | 24.5 [16, 75] | — | |
| IA | 70 [48, 127] | .13 | — |
| IA + G | 79 [63, 99] | .008 | NS |
| F + A | 27 [19, 61] | .022 | NS |
| FLAG | 42 [30, 63] | .27 | NS |
| FLAG + Ida | 36 [27, 43] | .001 | NS |
| RAEB | 22.5 [18-87] | .017 | NS |
| RAEB-t | 55 [36-77] | .78 | NS |
| AML | 55 [43-68] | .26 | — |
| Age | Decreases with increasing age, effect disappears by 40 wk post-CR | <.001 | .033 |
| AHD | Decreases with length of AHD up to plateau at AHD of 10-20 mo | <.001 | .017 |